YOLFTbeta
Tibet Aim Pharm Inc

Tibet Aim Pharm Inc

002826 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

14.93CNY-0.45 (-2.93%)

Price History

Full chart

Market Stats

Previous Close15.38
Open15.38
Day Range14.91 – 15.38
52-Week Range14.65 – 22.97
Volume4.39M
Market Cap3.35B
P/E (TTM)26.65
Forward P/E0.00
EPS0.66
Dividend Yield0.85%
Beta0.35
50-Day Avg17.15
200-Day Avg18.50

About

Tibet AIM Pharm. Inc. engages in the research and development, manufacturing, and sale of medical products in China. The company's products include Miglitol tablets for diabetes; ethnic medicine products, suitable for treating breast lobular hyperplasia, uterine fibroids, and ovarian cysts; medicines for gynecology and obstetrics; and Gualoupi injection, Nalmefene hydrochloride injection, and Carbetocin injection. It also provides Domperidone tablets for treatment of indigestion, abdominal bloating, belching, nausea, vomiting, and abdominal distension and pain; Montmorillonite powder for chronic diarrhea; and Hongjin Xiaojie tablets and Aceclofenac Enteric-Coated tablets, as well as for the treatment of antibiotics, antiallergic, and digestive systems. Tibet AIM Pharm. Inc. was founded in 2003 and is based in Lhasa, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Ke Xu
  • Employees405
  • HeadquartersNo. 6, Linqionggang Road, Lhasa, China, 850000, China
  • Websitehttps://www.emyy.cn

Leadership

  • Mr. Ke XuGM & CFO · b. 1978
  • Ms. Qianjin LiSecretary of the Board of Directors · b. 1977

Financials

Income Statement

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue221.11M290.73M347.00M451.92M380.29M488.77M553.26M602.62M725.46M856.73M667.04M651.88M636.27M
Growth (%)-+31.49%+19.35%+30.24%-15.85%+28.53%+13.19%+8.92%+20.38%+18.10%-22.14%-2.27%-2.39%
Cost of Revenue90.84M102.27M107.25M132.72M109.62M332.67M370.92M386.02M464.96M480.70M325.59M205.54M113.81M
Gross Profit130.27M188.46M239.75M319.20M270.67M156.10M182.33M216.60M260.50M376.03M341.45M446.34M522.46M
Gross Margin58.92%64.82%69.09%70.63%71.17%31.94%32.96%35.94%35.91%43.89%51.19%68.47%82.11%
Operating Expense116.03M158.50M194.29M272.05M205.57M129.25M134.63M173.48M211.87M320.30M317.95M384.84M423.86M
Operating Income14.24M29.97M45.46M47.15M65.10M26.86M47.70M43.13M48.64M55.73M23.50M61.50M98.60M
Operating Margin6.44%10.31%13.10%10.43%17.12%5.49%8.62%7.16%6.70%6.50%3.52%9.43%15.50%
EBITDA32.63M47.54M60.34M75.56M76.76M39.90M61.44M65.76M74.52M80.21M48.91M82.45M133.81M
EBITDA Margin14.76%16.35%17.39%16.72%20.18%8.16%11.10%10.91%10.27%9.36%7.33%12.65%21.03%
Net Income19.71M32.37M50.03M55.36M60.48M25.26M37.33M41.09M42.48M44.14M15.39M45.93M92.58M
Net Income Margin8.91%11.14%14.42%12.25%15.90%5.17%6.75%6.82%5.86%5.15%2.31%7.05%14.55%
R&D11.14M16.41M5.54M2.18M5.88M16.41M5.00M6.85M11.39M13.95M13.71M19.51M14.67M
R&D as % of Total Revenue5.04%5.64%1.60%0.48%1.55%3.36%0.90%1.14%1.57%1.63%2.06%2.99%2.31%
Interest Expense3.02M1.53M1.21M4.95M615.28K1.43M2.79M1.67M906.50K880.70K1.24M517.30K1.00M
Interest Expense % of Total Revenue1.36%0.53%0.35%1.10%0.16%0.29%0.50%0.28%0.12%0.10%0.19%0.08%0.16%

Balance Sheet

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets153.10M268.42M397.70M646.36M733.29M757.93M835.41M908.09M824.47M1.02B927.74M926.47M1.02B
Total Liabilities81.43M89.30M149.44M90.93M128.76M139.53M183.24M220.94M104.36M268.21M177.68M180.89M201.65M
Total Equity65.03M179.12M248.25M555.44M604.53M618.40M652.17M687.15M717.39M745.29M745.02M739.00M816.02M
Cash26.53M39.13M38.15M281.32M261.62M238.71M159.91M205.32M182.73M321.28M385.86M427.40M537.66M
Total Debt20.00M10.00M60.00M10.00M-40.00M70.00M40.00M6.65M50.05M11.01M22.82M-
Net Debt-6.53M-29.13M21.85M-271.32M-261.62M-198.71M-89.91M-165.32M-176.08M-271.23M-374.85M-404.58M-

Cash Flow

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow52.24M2.18M-29.69M57.18M77.29M13.31M59.20M101.74M109.52M68.45M166.88M111.57M123.72M
Investing Cash Flow-45.57M-61.32M-37.96M-18.47M-70.78M-63.46M-199.37M-7.85M-53.68M-1.72M-43.00M19.00M-
Financing Cash Flow3.19M71.74M66.67M204.49M-26.21M27.24M39.75M-46.78M-59.20M27.59M-59.30M-44.26M-
Capital Expenditure28.62M45.12M44.17M18.52M74.62M67.72M170.45M38.43M25.20M3.20M3.18M12.24M8.50M
Free Cash Flow23.62M-42.94M-73.86M38.66M2.67M-54.40M-111.25M63.31M84.33M65.26M163.70M99.33M115.22M
Dividends Paid1.81M3.26M766.34K3.50M11.38M12.76M5.69M7.67M15.27M19.01M20.28M6.04M23.84M
FCF to OCF45.22%-1965.86%248.77%67.61%3.46%-408.62%-187.91%62.23%77.00%95.33%98.09%89.03%93.13%
Dividend Paid to FCF7.68%-7.60%-1.04%9.05%425.96%-23.46%-5.12%12.12%18.11%29.13%12.39%6.08%20.69%

Earnings

Report DateFeb 23, 2017Apr 24, 2017Aug 18, 2017Oct 23, 2017Feb 26, 2018Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 28, 2020Aug 26, 2020Oct 29, 2020Dec 31, 2020Apr 28, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023May 17, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 16, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------------------------------
EPS Actual0.100.030.080.060.140.030.05-0.020.080.030.030.020.110.030.040.020.130.030.030.040.130.040.020.050.120.040.030.05-0.040.150.060.010.020.100.100.240.060.100.25
Surprise---------------------------------------
TimingPre-marketAfter-hoursAfter-hoursPre-marketPre-market------------------------After-hours---After-hours-----

Key Statistics & Ratios

Market Cap3.35B
Enterprise Value2.60B
Trailing P/E26.65
Forward P/E0.00
Price / Sales4.90
Price / Book3.79
EPS0.66
Book Value4.50
Revenue (TTM)684.45M
Gross Profit (TTM)565.51M
EBITDA85.31M
Profit Margin17.78%
Operating Margin16.12%
Return on Equity14.94%
Return on Assets3.86%
Shares Outstanding190.68M
Shares Float128.16M
Beta0.35
Dividend Yield0.85%
Dividend Rate0.15
Payout Ratio23.08%

Dividends

20261×
0.15Jun 9, 2026
20251×
0.10Jun 24, 2025
20241×
0.03May 31, 2024
20231×
0.10Jul 7, 2023
20221×
0.10Jul 8, 2022
20211×
0.08Jul 14, 2021
20201×
0.04Jul 14, 2020
20191×
0.03Jun 10, 2019
20181×
0.06May 28, 2018
20171×
0.06Jun 12, 2017